sch 16134 has been researched along with Drug Withdrawal Symptoms in 9 studies
quazepam: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307." | 9.07 | Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994) |
| "Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307." | 5.07 | Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994) |
| "Sixty-five patients, affected by sleep disorders, were entered into the study." | 2.67 | Quazepam versus triazolam in patients with sleep disorders: a double-blind study. ( Altamura, AC; Gianetti, S; Mauri, MC; Pugnetti, L, 1993) |
| "Temazepam did not produce any behavioral side effects during either drug condition." | 2.66 | Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal. ( Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR; Vela-Bueno, A, 1986) |
| "To assess pharmacodynamic and pharmacokinetic properties of acute, subchronic and withdrawn quazepam, a single-blind, longitudinal study was run in eight male, healthy young volunteers." | 1.28 | Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam. ( Kauert, G; Klausnitzer, W; Schaffler, K; Wauschkuhn, CH, 1989) |
| " Some loss of effectiveness was noted during long-term use of both doses of quazepam and, to a lesser extent, of flurazepam." | 1.26 | Quazepam and flurazepam: long-term use and extended withdrawal. ( Bixler, EO; Jacoby, J; Kales, A; Kales, JD; Soldatos, CR; Vela-Bueno, A, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kales, A | 5 |
| Scharf, MB | 1 |
| Bixler, EO | 4 |
| Schweitzer, PK | 1 |
| Jacoby, JA | 3 |
| Soldatos, CR | 5 |
| Tietz, EI | 1 |
| Roth, T | 1 |
| Zorick, FJ | 1 |
| Piccione, P | 1 |
| Kramer, M | 1 |
| Vela-Bueno, A | 2 |
| Jacoby, J | 1 |
| Kales, JD | 4 |
| Mauri, MC | 1 |
| Gianetti, S | 1 |
| Pugnetti, L | 1 |
| Altamura, AC | 1 |
| Saletu, B | 1 |
| Anderer, P | 1 |
| Brandstätter, N | 1 |
| Frey, R | 1 |
| Grünberger, J | 1 |
| Klösch, G | 1 |
| Mandl, M | 1 |
| Wetter, T | 1 |
| Zeitlhofer, J | 1 |
| Schaffler, K | 1 |
| Kauert, G | 1 |
| Wauschkuhn, CH | 1 |
| Klausnitzer, W | 1 |
1 review available for sch 16134 and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D | 1985 |
5 trials available for sch 16134 and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; | 1981 |
Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Human | 1993 |
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics | 1994 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D | 1985 |
Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Drug Evaluation; Half-L | 1986 |
4 other studies available for sch 16134 and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Dose-response studies of quazepam.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; | 1981 |
Quazepam and flurazepam: long-term use and extended withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Drug Evaluation; Flurazepam; Half-Life; Humans; Middle | 1982 |
Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Electrooculography; Flurazepam; Hemo | 1989 |
Quazepam: sleep laboratory studies of effectiveness and withdrawal.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders | 1985 |